Although caffeine is commonly consumed during pregnancy, there are few reports on the association of in utero caffeine exposure with offspring cognition or behavior during childhood. We evaluated the association of maternal serum paraxanthine, caffeine's primary metabolite, at <20 and ≥26 weeks' gestation with the child's intelligence quotient (IQ) and problem behaviors at ages 4 and 7 years among 2,197 mother-child pairs. The mothers were controls from a case-control study of caffeine metabolites and spontaneous abortion that was nested within the Collaborative Perinatal Project (multiple US sites, [1959][1960][1961][1962][1963][1964][1965][1966][1967][1968][1969][1970][1971][1972][1973][1974]. Associations of paraxanthine (adjusted for maternal age, race, education, smoking, prepregnancy weight, gestational age at blood draw, and child sex) with mean IQ were assessed by linear regression and associations with problem behaviors by logistic regression. Paraxanthine concentration at ≥26 weeks' gestation manifested an inverted-J-shaped association with child's IQ at age 7 years, with a peak difference (vs. undetectable) of 0.65 points at 750 µg/L (66th percentile) and a decrement thereafter. Paraxanthine at <20 weeks was linearly associated with internalizing behavior at age 4 years (for a 500-µg/L increase, odds ratio = 1.3, 95% confidence interval: 1.1, 1.5). None of the remaining 12 associations approached statistical significance. We conclude that over a range of values applicable to most pregnant women, there was no meaningful association of serum paraxanthine level with childhood IQ or problem behaviors. caffeine; childhood behavior; childhood cognition; paraxanthine; pregnancy Abbreviations: CPP, Collaborative Perinatal Project; CYP1A2, cytochrome P-450 1A2; IQ, intelligence quotient.
Caffeine is commonly consumed by pregnant women (1) (2) (3) . Caffeine intake during pregnancy has been variably associated with spontaneous abortion (4, 5) and small-for-gestational-age birth (4, 6) , but in spite of the near ubiquity of in utero caffeine exposure, few studies have evaluated the association between fetal caffeine exposure and childhood outcomes beyond the immediate neonatal period.
Prenatal caffeine exposure has long-term behavioral effects in rats (7) , but few studies have evaluated the association between caffeine exposure during pregnancy and behavioral outcomes in childhood. One study found that heavy maternal caffeine consumption during pregnancy was associated with increased infant nighttime awakening at 3 months of age (8) , but another found no evidence of increased problem behaviors at age 5-6 years with increasing maternal pregnancy consumption (9) . One study found a small association between caffeine intake during pregnancy and maternally reported child inattention and overactivity at age 18 months (10); and in another study, consumption of ≥10 cups/day was associated with a nonsignificant 2.3-fold increased risk of clinically diagnosed hyperkinetic disorder and attentiondeficit/hyperactivity disorder (11) . We are aware of only 1 study of in utero caffeine exposure and child cognition; in a cohort of 500 children, exposure was not associated with intelligence quotient (IQ) at age 7 years (12) . We studied the association between maternal serum concentration of paraxanthine, the primary metabolite of caffeine in humans, at 2 points in pregnancy and the child's cognitive and behavioral outcomes at 4 and 7 years of age in the Collaborative Perinatal Project (CPP) cohort.
METHODS
This was a secondary analysis of women selected as controls for a nested case-control study of caffeine metabolites and miscarriage conducted within the CPP cohort (13) . The CPP was a prospective cohort study (14) that recruited pregnant women at 12 academic medical centers in the United States from 1959 to 1965; it was not designed to select a statistically representative sample (15) . As controls, the women gave birth to liveborn infants at ≥28 completed weeks of gestation and had serum drawn on the same gestational day as a woman, recruited at the same clinical site, who subsequently experienced a miscarriage at <20 completed weeks' gestation (13) .
CPP serum was stored in glass vials at −20°C, with no recorded thaws from collection to analysis for caffeine, paraxanthine, theobromine, and theophylline in [1997] [1998] [1999] . In addition to analysis of control women's serum drawn at <20 weeks' gestation ("early pregnancy"), the first sample drawn at or after 26 weeks' gestation ("third trimester") was also analyzed, originally to assess the association between paraxanthine and the delivery of a small-for-gestational age infant (16) . Serum was analyzed by high-performance liquid chromatography (17) , with limits of detection and quantitation of 25 µg/L and 50 µg/L (the lowest value of the standard curve), respectively. Actual machine values were not available, so we assumed values of 0 and 37 µg/L (midway between the limits of quantitation and detection) for samples with levels below the limit of detection (14% of early-pregnancy samples and 9% of third-trimester samples) and quantitation (4% and 3%), respectively. In previous investigations, different choices for these values did not change results (16, 18, 19) . Paraxanthine was chosen as the marker for caffeine exposure because it was shown to correlate more strongly than serum caffeine with concurrently recalled 24-hour caffeine intake, particularly among smokers (17) . Serum paraxanthine level also varies less than serum caffeine with acute caffeine ingestion (20) .
CPP children underwent a standardized battery of cognitive and motor tests, administered by project psychologists at in-person visits made at 4 and 7 years of age. IQ was estimated by means of the Stanford-Binet Intelligence Scale at age 4 years (21) and the Wechsler Intelligence Scale for Children at age 7 years (22) . Based upon their interactions with the child and their observations during a period of free play, the psychologists completed a series of structured scales to rate the child's behavior using a validated scheme; details of the validation have been previously described (23) (24) (25) . Donatelli et al. (26) employed principal-components analysis of the ratings to identify individual behavioral symptoms that clustered together into specific problem behaviors in a subset of CPP children (see Web Table 1 , available at http://aje. oxfordjournals.org/). They identified 3 clusters at age 4 years (hyperactive, internalizing, and oppositional behavior) and 2 clusters at age 7 years (externalizing and internalizing behavior). As per Donatelli et al. (26) , we classified children as to whether they manifested each component behavior (0 = no, 1 = somewhat, 2 = very much) and summed the item scores to form a score for each cluster (25) . The score distributions were highly skewed, with 60%-75% of children having a score of 0; therefore, for each cluster we chose, a priori, a score of 1, 2, 3, or 4 points to define a binary variable that identified approximately the highest 10% of children.
The associations between early-pregnancy and thirdtrimester serum paraxanthine concentrations and IQ at 4 and 7 years of age were evaluated by linear regression. Because several log-binomial (27) and modified Poisson (28) models failed to converge, we estimated associations with binary outcomes by logistic regression to obtain odds ratios. Serum paraxanthine concentration was considered as a restricted cubic spline with 3 knots, and overall significance was assessed by means of Wald tests with 2 degrees of freedom. When the P value for the paraxanthine spline term in an adjusted model was greater than 0.05, the analysis was repeated with paraxanthine entered as a simple continuous term to evaluate the possibility of a linear trend. Because approximately 3% of observations were repeated pregnancies in the same mother, standard errors were derived using generalized estimating equations (29) . All P values are 2-sided.
Associations were adjusted for the following characteristics, chosen a priori: maternal age (years), education (years), race (white, nonwhite), smoking (cigarettes/day), prepregnancy weight (kg), duration of gestation (by menstrual dating) at blood draw (days), and child sex (male, female). Weight was chosen instead of body mass index to minimize missing data (18) . We also evaluated maternal smoking and child sex as effect-measure modifiers by including the relevant interaction terms in our adjusted models. The CPP did not collect data on maternal or child caffeine intake, maternal alcohol use, or breastfeeding after the nursery stay. A nonverbal IQ test (Scientific Research Associates, Inc., New York, New York) was administered to a subsample of 45% of mothers when the child was 4 years of age (30) ; secondary analyses included maternal IQ. Characteristics that were continuous were entered into models as such, although they are categorized for presentation in Table 1 . Continuous variables, except for duration of gestation at blood draw and maternal age, were entered into models as restricted cubic splines with 3 knots (the nonlinear terms for the latter characteristics were not statistically significantly associated with any outcome in adjusted models).
To assess the potential role of loss to follow-up, the probability of successful follow-up, defined as the presence of any outcome data at ages 4 and 7 years, was assessed in 4 logistic models (for each combination of time of blood draw and age at follow-up). The model included the above-noted confounders plus serum paraxanthine, study site, child's birth weight and gestational age, and whether follow-up was successful at 7 years (for 4-year outcomes) or 4 years (for 7-year outcomes). The 7-year models also included whether maternal IQ was assessed when the child was 4 years of age. The adjusted analyses were then conducted, weighting each individual by the inverse of his/her probability of successful follow-up.
Analyses were conducted using SAS, version 9.3 (SAS Institute, Inc., Cary, North Carolina), and a macro for restricted cubic splines (31) that was modified to incorporate weights. Graphs were generated using Stata, version 13 (StataCorp LP, College Station, Texas). This analysis was deemed exempt from review by the Nationwide Children's Hospital Institutional Review Board (Nationwide Children's Hospital, Columbus, Ohio).
RESULTS
The original study included 2,816 control pregnancies of at least 28 weeks' gestation, 2,808 of which had at least 1 sample analyzed for caffeine and primary metabolites. After exclusion of 35 twin pregnancies and 8 samples with missing paraxanthine data, there were 2,765 pregnancies, of which 2,726 had early-pregnancy samples assayed and 2,515 had third-trimester samples assayed. Among the 2,726 pregnancies with early-pregnancy samples, 53 children died before age 4 years and 4 more died between ages 4 and 7 years; 1,982 (74%) and 2,070 (78%) children had data for at least one 4-and 7-year outcome, respectively. Among the 2,515 pregnancies with third-trimester samples, 48 children died before age 4 years and 4 more died between ages 4 and 7 years; 1,862 (75%) and 1,947 (79%) survivors had data for at least one 4-and 7-year outcome, respectively. There were 2,197 mother-child pairs with at least 1 paraxanthine value and data on at least 1 outcome. Exclusion of children with missing covariates resulted in a final study sample containing 1,915 and 1,995 children with 4-and 7-year measures for pregnancies with early-pregnancy samples and 1,798 and 1,876 children with 4-and 7-year measures for those with third-trimester samples.
The 25th, 50th, 75th, and 90th percentiles for early-pregnancy paraxanthine concentration were 97 µg/L, 383 µg/L, 870 µg/L, and 1,405 µg/L, respectively; corresponding third-trimester values were 187 µg/L, 522 µg/L, 941 µg/L, and 1,526 µg/L. Table 1 presents the distribution of participant characteristics by paraxanthine concentration, IQ, and behavioral outcomes. Serum paraxanthine level increased with increasing maternal age and with the number of cigarettes smoked per day. White women had substantially greater paraxanthine concentrations than nonwhite women at both time points, and concentrations at both time points were slightly higher for male fetuses than for female fetuses. Early-pregnancy paraxanthine concentration declined somewhat with increasing maternal education, and it increased the later in pregnancy that serum was collected. Third-trimester paraxanthine concentration decreased with increasing prepregnancy weight. Among the women whose IQ was assessed, there was no clear trend in the relationship between paraxanthine levels and IQ scores.
Children of the youngest mothers had the lowest IQs at ages 4 and 7 years. Child IQ at both ages increased with increasing years of maternal education and increasing maternal IQ, and children of nonwhite women had lower IQs at both ages. Girls had higher IQs than boys at age 4 years. Internalizing behavior at age 4 years, but not age 7 years, increased with increasing maternal age and was greater at both time points among children of less educated women, women with lower IQ scores, and nonwhite women. Hyperactive behavior at age 4 years was more common in boys than in girls and was slightly more common among children of the youngest women, women who smoked, and women with less education. Oppositional behavior at age 4 years tended to decrease with increasing maternal prepregnancy weight, increasing years of maternal education, and increasing IQ. Boys exhibited substantially more oppositional behavior than girls. Externalizing behavior at age 7 years increased with increasing maternal cigarette use, increasing maternal prepregnancy weight, and increasing maternal IQ. Boys exhibited more externalizing behavior than did girls. Table 2 presents the overall P value and P values for nonlinearity of the adjusted and unadjusted associations of IQ and behavior with paraxanthine; when the P value for nonlinearity of the adjusted association was greater than 0.05, Table 2 also presents the P value for a simple linear trend. Adjusted associations with IQ are presented in panels A (4-year IQ by earlypregnancy paraxanthine), B (7-year IQ by early-pregnancy paraxanthine), C (4-year IQ by third-trimester paraxanthine), and D (7-year IQ by third-trimester paraxanthine) of Figure 1 . The corresponding unadjusted associations are presented in Web Figure 1A -D. The adjusted associations between earlypregnancy paraxanthine and IQ at both time points were generally monotonic and weakly, albeit nonsignificantly, negative. Adjusted associations between third-trimester paraxanthine and 4-and 7-year IQ manifested inverted-J shapes, but only the association with 7-year IQ was statistically significant (overall P = 0.05; P for nonlinearity = 0.04), with the peak IQ (compared with undetectable paraxanthine) of 0.65 points appearing at approximately 750 µg/L (66th percentile) and a decrement thereafter. There was a suggestion of an influence of the interaction between third-trimester paraxanthine and sex on 7-year IQ (P = 0.07). In stratified analyses, the doseresponse curve was similar for girls and boys, but it was of lower magnitude and not statistically significant for girls. No other influence of the interaction of paraxanthine concentration at either time with sex or smoking on IQ approached statistical significance (smallest P = 0.23). Adjustment substantially diminished the magnitude of the dose-response as compared with the unadjusted response.
Web Figure 2 presents adjusted associations with behavior; the first row shows results for early-pregnancy paraxanthine and the second row shows results for third-trimester paraxanthine. Columns 1-5 represent hyperactivity, internalizing, and oppositional behavior at age 4 years and externalizing and internalizing behavior at age 7 years, respectively. The corresponding unadjusted associations are presented in Web Figure 3 . As noted in Web Figure 2 , early-pregnancy paraxanthine manifested a negative adjusted association with hyperactive behavior at age 4 and with internalizing behavior at age 7, a "ceiling" association with internalizing behavior at age 4, and positive associations with oppositional behavior at age 4 and externalizing behavior at age 7. However, none of the associations approached statistical significance. For thirdtrimester paraxanthine, there were J-shaped associations with internalizing and hyperactive behaviors at age 4 and externalizing behavior at age 7. Oppositional behavior at age 4 increased slightly with increasing paraxanthine, manifesting a ceiling, and the association of paraxanthine with internalizing behavior at age 7 had an inverted J-shape. Only the overall (2 degrees of freedom) association between paraxanthine and internalizing behavior at age 4 was statistically significant (P = 0.002); since the P value for nonlinearity did not approach significance, we evaluated a simple linear trend, which also proved statistically significant. No interaction between either paraxanthine value and sex or smoking approached significance for the behavioral outcomes (smallest Abbreviations: IQ, intelligence quotient; SD, standard deviation; WISC, Wechsler Intelligence Scale for Children. a There were 2,179 pregnancies with complete data on paraxanthine at <20 weeks, covariates, and at least 1 outcome at 4 and/or 7 years of age. b There were 2,049 pregnancies with complete data on paraxanthine at ≥26 weeks, covariates, and at least 1 outcome at 4 and/or 7 years of age. c There were 1,940 children with at least 1 outcome measured at age 4 years, data on all covariates, and either early-pregnancy or third-trimester maternal serum paraxanthine measurements.
d There were 2,024 children with at least 1 outcome measured at age 7 years, data on all covariates, and either early-pregnancy or third-trimester maternal serum paraxanthine measurements.
e Cutpoints for length of gestation at <20-week blood draw. f Cutpoints for length of gestation at ≥26-week blood draw. Figure 3) . Associations additionally adjusted for maternal IQ in the subset of participants among whom it was assessed are presented in Figure 2 and Web Figure 4 ; P values for these associations are presented in Table 2 . In most instances the general shapes of the associations were similar to the corresponding curves that did not adjust for maternal IQ, and statistically significant associations from the previous adjusted analysis retained significance. However, the odds ratio for the relationship between early-pregnancy paraxanthine and hyperactive behavior at age 4 years now manifested a statistically significant inverse association; and the relationships between third-trimester paraxanthine and internalizing behavior at age 4 years and externalizing behavior at age 7 years now manifested a statistically significant J-shaped association with nadirs at approximately 750 µg/L and 950 µg/L, respectively. In sensitivity analyses, the latter 3 associations were evaluated, unadjusted, among the subset of pregnancies where maternal IQ was present. Findings similar to the adjusted ones were observed (data not shown), suggesting that these results reflected a situation where the association between paraxanthine and these 3 outcomes happened to differ between women with and without IQ data present, rather than specific confounding by IQ.
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Additional analyses in which participants who completed the 4-and/or 7-year evaluations were weighted by the inverse of their probability of successful follow-up produced results not meaningfully different from those in Figure 1 and Web Figure 2 . Additional adjustment for maternal self-reported psychiatric diagnoses and use of tranquilizers, sleeping pills, and/or diet/"pep" pills in the year before study registration produced a minimal difference in the results (data not shown). 
DISCUSSION
This study found that over a range of serum paraxanthine concentrations encompassing the majority of pregnant women, there was little evidence of an adverse association between maternal serum paraxanthine level and the cognitive and behavioral status of the child at ages 4 and 7 years. However, at very high third-trimester paraxanthine concentrations, we observed several nonlinear associations suggestive of lower IQ at age 7 and elevated internalizing behavior at age 4 and externalizing behavior at age 7 (the latter two after additional adjustment for maternal IQ). We also observed an inverse association between maternal paraxanthine concentration at less than 140 days' gestation and child hyperactive behavior at age 4 years. However, there was no consistent pattern in these associations. For example, the association between paraxanthine at both time points and internalizing behavior at age 4 was in the opposite direction from the association between paraxanthine and internalizing behavior at age 7. At very high paraxanthine values, adverse effects could not be ruled out, but our data were sparse at these values and estimates were imprecise. Taken as a whole, we consider our results to be reassuring for pregnant women who consume typical amounts of caffeine.
We are aware of only 1 previous study that evaluated the association between maternal caffeine intake during pregnancy and cognitive development in the child. Among approximately 500 children followed to age 7 years, Barr and Streissguth (12) reported no association between maternal prenatal caffeine consumption and Wechsler Intelligence Scale for Children IQ score, but they did not present numerical estimates; they presented only a P value of 0.68. They also reported no significant association between caffeine and errors of commission (P = 0.92) and omission (P = 0.86) on the Continuous Performance Test (12) . In the same cohort, at age 4 years they reported more errors in fine motor steadiness with in utero caffeine exposure but faster time to correct the errors, as well as more pegs dropped during the grooved pegboard test; they considered these results to be inconsistent (12) . In a Dutch prospective study, no statistically significant association was observed between maternal caffeine intake during pregnancy and overall problem behavior or 5 specific problem behaviors as reported on the Strengths and Difficulties Questionnaire when the children were 5-6 years of age; most odds ratios were less than 1 (9) . In follow-up of a Danish cohort, Linnet et al. (11) found that children whose mothers consumed 4-9 cups of coffee per day during pregnancy (vs. no coffee during pregnancy) had a relative risk for confirmed hyperkinetic disorder or attention-deficit/hyperactivity disorder of 1.3 (95% confidence interval: 0.7, 2.3); the relative risk for 10 or more cups per day was 2.3 (95% confidence interval: 0.9, 5.9).
In an analysis of data from the Norwegian Mother and Child Cohort Study, Bekkhus et al. (10) reported that maternal caffeine intake from soft drinks (specifically not coffee and tea) at 17 weeks' and 30 weeks' gestation was significantly associated with child inattention/overactivity (mainly accounted for by overactivity) as assessed at age 18 months by the Child Behavior Checklist. Only P values, rather than point estimates or even the direction of the association, were presented. The specificity of the association with soft drinks suggests either an effect of compounds contained in soft drinks but not in other sources of caffeine or unmeasured confounding by characteristics that differ between women who consume soft drinks and women who ingest caffeine from other sources. In comparison, over most of the range of paraxanthine concentrations, we observed a negative association with hyperactive behavior at age 4 years.
Our study had several strengths. Most important is that IQ was measured and behavior assessed using validated measures in a large number of children by trained psychologists who underwent ongoing quality monitoring. Most previous studies of behavior relied on maternal reports, raising concerns that mothers who consume caffeine might perceive behaviors differently than mothers who do not. Second, our study was conducted in an era when coffee consumption during pregnancy was more prevalent (32) than in contemporary Results were adjusted for infant sex and maternal IQ, age, race, education, smoking, prepregnancy weight, and gestational age at blood draw. Data points on the y-axis are truncated at +5 and −5. A) IQ at age 4 by serum paraxanthine at <20 weeks; B) IQ at age 7 by serum paraxanthine at <20 weeks; C) IQ at age 4 by serum paraxanthine at ≥26 weeks; D) IQ at age 7 by serum paraxanthine at ≥26 weeks. Outer curves, 95% confidence intervals. pregnant populations (33) and there was little concern regarding the safety of caffeine. Therefore, our study is likely to have contained a broader range of serum paraxanthine values than would a more recent cohort. Third, maternal IQ was measured in a subset of the mothers. Finally, maternal serum was collected prospectively during pregnancy, and we employed a biomarker for caffeine, thereby bypassing possible errors in recall or reporting of caffeine intake. However, our study had limitations. Most importantly, the CPP collected no data on maternal alcohol intake. Alcohol use and caffeine use among pregnant women have been positively correlated in numerous studies (9, 12, 34) , and alcohol is known to have detrimental effects on child cognition and behavior (35) . The nonlinear associations we observed (lower IQ and higher odds of several adverse behaviors) among the women with the highest paraxanthine concentrations might reflect unmeasured confounding by alcohol. However, given the expected direction of confounding, failure to control for alcohol use is unlikely to account for the largely reassuring results we observed. Second, the CPP did not measure children's diets. Mothers who consumed caffeine during pregnancy might serve caffeinated drinks to their children, but unless caffeine had beneficial effects on child cognition or behavior, this would be unlikely to account for our results. Third, the CPP was not a statistically representative sample of pregnant women; however, the value of statistical representativeness in epidemiologic investigation is dubious (36) . Fourth, maternal smoking was more prevalent in the CPP than in contemporary populations (37) . Because smokers metabolize caffeine more rapidly than do nonsmokers (38) , a given serum paraxanthine value may correspond to higher caffeine intake in the CPP cohort than in a more modern cohort. However, we did not observe significant interactions between smoking and paraxanthine level for any outcome. Fifth, paraxanthine correlates well with recent caffeine intake (17, 39), but we had measures from only 2 points in pregnancy. While wide differences in caffeine metabolism between women and within an individual woman over the course of pregnancy make it difficult to correlate serum paraxanthine concentration with a specific caffeine intake, we previously estimated that a concentration of 1,845 µg/L (approximately 95th percentile) corresponds to approximately 600 mg of caffeine (6 cups of coffee) per day for a 60-kg (132-pound) woman who did not smoke and 1,100 mg (11 cups of coffee) per day for a 60-kg women who smoked (17) . Finally, paraxanthine is a marker for both caffeine intake and metabolism; in response to the hormonal changes of pregnancy, the activity of cytochrome P-450 1A2 (CYP1A2), the enzyme that metabolizes caffeine to paraxanthine, declines as pregnancy progresses (40) . Since failure of CYP1A2 to decline results in a higher paraxanthine concentration for a given caffeine intake (41) , an abnormal pregnancy per se may cause an increased paraxanthine concentration.
In summary, over the range of paraxanthine levels observed in the majority of women in this cohort, we did not find evidence of an adverse association of maternal pregnancy caffeine consumption with child cognition or behavior at 4 or 7 years of age. Unmeasured confounding by alcohol intake is unlikely to account for the findings. On balance, our results provide reassurance to the majority of pregnant women who consume moderate amounts of caffeine.
